David Tyronne Howton, Jr

2013

In 2013, David Tyronne Howton, Jr earned a total compensation of $2.6M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$165,178
Option Awards$2,086,290
Salary$376,913
Other$12,518
Total$2,640,899

Howton received $2.1M in option awards, accounting for 79% of the total pay in 2013.

Howton also received $165.2K in non-equity incentive plan, $376.9K in salary and $12.5K in other compensation.

Rankings

In 2013, David Tyronne Howton, Jr's compensation ranked 2,939th out of 12,286 executives tracked by ExecPay. In other words, Howton earned more than 76.1% of executives.

ClassificationRankingPercentile
All
2,939
out of 12,286
76th
Division
Manufacturing
976
out of 4,612
79th
Major group
Chemicals And Allied Products
257
out of 1,462
82nd
Industry group
Drugs
175
out of 1,156
85th
Industry
Pharmaceutical Preparations
145
out of 890
84th
Source: SEC filing on May 31, 2016.

Howton's colleagues

We found four more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2013.

2013

Christopher Garabedian

Sarepta Therapeutics

Chief Executive Officer

2013

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

2013

Edward Kaye

Sarepta Therapeutics

Chief Executive Officer

2013

Jayant Aphale

Sarepta Therapeutics

Senior Vice President, Technical Operations

News

In-depth

You may also like